Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised, Evaluator-Blinded, Two-Arm Study To Evaluate The Safety And Efficacy of a Novel Microneedle and Laser-Based Medical Device For The Treatment of Androgenetic Alopecia in Adult Males

NCT05970809 is registered in ClinicalTrials.gov with StimuSIL as lead sponsor.

NCT NCT05970809
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05970809 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised, Evaluator-Blinded, Two-Arm Study To Evaluate The Safety And Efficacy of a Novel Microneedle and Laser-Based Medical Device For The Treatment of Androgenetic Alopecia in Adult Males
Lead sponsor
StimuSIL
Phase
Not applicable
Overall status
Completed
Start date
June 1, 2023
Completion date
October 24, 2024
Enrollment
82 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

androgenetic alopecia, hair loss, hair loss/baldness, male pattern baldness, pattern baldness